Dr. Travis P. Taylor, MD
Interventional Cardiology (Interventional Cardiology Physician)
601 Texan Trl
Corpus Christi, TX 78411
Who else practices at this address →
Nueces County includes mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 907
Licensed in Texas since 2017, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Indiana University School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license R1892 (first issued 2017; active) -
Cardiovascular Disease Physician
TX license R1892 (first issued 2017; active) -
Internal Medicine Physician
TX license R1892 (first issued 2017; active) -
Nuclear Cardiology Physician
TX license R1892 (first issued 2017; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Christus Spohn Hospital Corpus Christi Corpus Christi, TX
- Corpus Christi Medical Center,the Corpus Christi, TX
- Christus Spohn Hospital Kleberg Kingsville, TX
Medical groups
- Shea Physical Therapy Specialists LLC (202 clinicians)
- Coastal Cardiology Association (9 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 907
- Services billed
- 4,713
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 920 | 550 |
| Established patient office or other outpatient visit, 30-39 minutes | 711 | 419 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 324 | 61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 306 | 298 |
| New patient office or other outpatient visit, 45-59 minutes | 187 | 187 |
| Established patient office or other outpatient visit, 20-29 minutes | 163 | 156 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 147 | 54 |
| Injection, regadenoson, 0.1 mg | 120 | 30 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 102 | 57 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 87 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Corpus Christi, TX | 755 |
| Metoprolol Succinate Other prescribers in Corpus Christi, TX | 598 |
| Amlodipine Besylate Other prescribers in Corpus Christi, TX | 512 |
| Furosemide Other prescribers in Corpus Christi, TX | 477 |
| Eliquis (apixaban) Other prescribers in Corpus Christi, TX | 426 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Corpus Christi, TX | 369 |
| Losartan-Hydrochlorothiazide (losartan/hydrochlorothiazide) Other prescribers in Corpus Christi, TX | 338 |
| Losartan Potassium Other prescribers in Corpus Christi, TX | 337 |
| Spironolactone Other prescribers in Corpus Christi, TX | 303 |
| Entresto (sacubitril/valsartan) Other prescribers in Corpus Christi, TX | 240 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 46 payments worth $1,392 in total to this clinician.
| Medtronic, Inc. | $460 |
|---|---|
| Abbott Laboratories | $150 |
| Novartis Pharmaceuticals Corporation | $131 |
| Philips North America LLC | $121 |
| Abiomed | $117 |
| Boston Scientific Corporation | $110 |
| Recor Medical Inc | $70.30 |
| AstraZeneca Pharmaceuticals LP | $58.75 |
| Food and Beverage | $1,392 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $324,273 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Eli Lilly and Company · Active, not recruiting · NCT06292013 - The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390 - A Randomised,Double Blind,Placebo Controlled,Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants with Uncontrolled Hypertension on Two or More Medications including Participants with R…
AstraZeneca Pharmaceuticals LP - A Randomised Double-Blind Placebo-Controlled Parallel Group Study to Assess the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants with Resistant Hypertension
AstraZeneca Pharmaceuticals LP - A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Diseas…
AstraZeneca Pharmaceuticals LP
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.